Edward Kim, MD of Levine Cancer Institute explains how anti-PD-L1 and PD-1 therapies are being combined with chemotherapy and targeted therapies in treating lung cancer at the 2017 Annual Meeting Annual Meeting in Chicago, IL.
How are anti-PD-L1/PD-1 therapies being combined with chemotherapy and targeted therapies in the treatment of lung cancer?
